MONARCH Platform for Bronchoscopy Receives Regulatory License for China

The MONARCH™ Platform is the first minimally invasive, robotic-assisted technology approved for bronchoscopy in a country with significant burden of lung cancer. REDWOOD CITY, Calif., Nov. 13, 2023 /PRNewswire/ — Johnson & Johnson MedTech* today announced that the MONARCH Platform and…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks